Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AE Protease inhibitors
J05AE09 Tipranavir
D08605 Tipranavir (INN) <US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Protease Inhibitors (PI)
Tipranavir
D08605 Tipranavir (INN)
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG01647 HIV protease inhibitor
DG00658 Tipranavir
D08605 Tipranavir
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D08605 Tipranavir
Antimicrobials [BR:br08307]
Antivirals
Polyprotein cleavage inhibitor
HIV protease inhibitor
D08605 Tipranavir (INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08605
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08605
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08605
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG01647 HIV protease inhibitor
DG00658 Tipranavir
Antimicrobials abbreviations [BR:br08327]
Antivirals
Polyprotein cleavage inhibitor
HIV protease inhibitor
DG00658 Tipranavir